VIVITROL® (naltrexone for extended-release injectable suspension) 380 mg/vial
Company

VIVITROL® (naltrexone for extended-release injectable suspension) 380 mg/vial

Pharmaceutical Manufacturing 1 employees
Employees
1

VIVITROL® (naltrexone for extended-release injectable suspension) 380 mg/vial Overview

Industry
Pharmaceutical Manufacturing
Employees
1
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
Keywords

About VIVITROL® (naltrexone for extended-release injectable suspension) 380 mg/vial

Please see full Prescribing Information at https://www.vivitrol.com/content/pdfs/prescribing-information.pdf. This product information is intended for US Healthcare Professionals only. You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. ALKERMES® and VIVITROL® are registered trademarks of Alkermes, Inc. ©2025 Alkermes, Inc. All rights reserved. VIV-007364

Compare Similar Companies to VIVITROL® (naltrexone for extended-release injectable suspension) 380 mg/vial